BackAclarion- Warrants (01/12/2026) Overview

Aclarion- Warrants (01/12/2026) Current Cash

Latest current cash for ACONW: $19M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$19.00M
28.84% YoYΔ $4.25M vs prior year quarter

Peer average

Loading

Aclarion- Warrants (01/12/2026) Current Cash History

Loading

Aclarion- Warrants (01/12/2026) vs. peers: Current Cash Comparison

Loading

Aclarion- Warrants (01/12/2026) Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Aclarion- Warrants (01/12/2026) (ACONW) FAQ

The latest current cash for ACONW is $19M as of March 2026. That compares with $15M in the prior-year period — up 28.8% year over year. Investors often review this figure alongside Aclarion- Warrants (01/12/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, ACONW's current cash moved from $15M to $19M — a 28.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aclarion- Warrants (01/12/2026)'s operating scale or balance-sheet position.

A current cash figure of $19M for ACONW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ACONW's current cash ($19M), review year-over-year change from $15M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Aclarion- Warrants (01/12/2026)'s current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.